Sodium Potassium Chloride Symporter Inhibitors
-
Subject Areas on Research
- A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials.
- A reappraisal of loop diuretic choice in heart failure patients.
- Advances in the pharmacological management of breathlessness.
- Approaches to decongestion in patients with acute decompensated heart failure.
- Association between Furosemide Exposure and Patent Ductus Arteriosus in Hospitalized Infants of Very Low Birth Weight.
- Chloride transport inhibitors influence recovery from oxygen-glucose deprivation-induced cellular injury in adult hippocampus.
- Combination of loop diuretics with thiazide-type diuretics in heart failure.
- Dangerous diuretics or death defying drugs?
- Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials.
- Diuretic Treatment in Heart Failure.
- Diuretic management in heart failure.
- Diuretic strategies in patients with acute decompensated heart failure.
- Diuretics and ultrafiltration in acute decompensated heart failure.
- Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis.
- Haemodynamic effects of rolofylline in the treatment of patients with heart failure and impaired renal function.
- INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) Profiling Identifies Ambulatory Patients at High Risk on Medical Therapy After Hospitalizations for Heart Failure.
- Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial.
- Loop diuretic adjustments in patients with chronic heart failure: Insights from HF-ACTION.
- Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF.
- Loop diuretics have anxiolytic effects in rat models of conditioned anxiety.
- Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil?
- Loop diuretics in heart failure.
- Necrotizing enterocolitis and the use of loop diuretics in very low birth weight neonates.
- Off-label use of cardiovascular medications in children hospitalized with congenital and acquired heart disease.
- Pharmacologic approaches for volume excess in acute kidney injury (AKI).
- Physician-determined worsening heart failure: a novel definition for early worsening heart failure in patients hospitalized for acute heart failure--association with signs and symptoms, hospitalization duration, and 60-day outcomes.
- Rationale and Design of the ATHENA-HF Trial: Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy in Heart Failure.
- Red blood cell distribution width and 1-year mortality in acute heart failure.
- Reduction in body weight but worsening renal function with late ultrafiltration for treatment of acute decompensated heart failure.
- Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial.
- The Importance of Worsening Heart Failure in Ambulatory Patients: Definition, Characteristics, and Effects of Amino-Terminal Pro-B-Type Natriuretic Peptide Guided Therapy.
- The chloride transporter Na(+)-K(+)-Cl- cotransporter isoform-1 contributes to intracellular chloride increases after in vitro ischemia.
- Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial).
- Torsemide versus furosemide in heart failure patients: insights from Duke University Hospital.
- Use of Heart Failure Medical Therapies Among Patients With Left Ventricular Assist Devices: Insights From INTERMACS.
- Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury.
-
Keywords of People
- O'Connor, Christopher Michael, Richard Sean Stack, M.D. / Guidant Foundation Professor of Cardiology, Medicine, Clinical Pharmacology